Dalteparin SodiumThird Party Manufacturing in India

Dalteparin Sodium works by enhancing the body's natural anti-clotting mechanism to prevent the formation of harmful blood clots.

The molecule binds selectively to antithrombin III, inducing a structural change that accelerates the neutralization of activated coagulation factors. It has a high selectivity for neutralizing Factor Xa, while having a much weaker inhibitory effect on thrombin (Factor IIa). By stopping Factor Xa from converting prothrombin to thrombin, it prevents the subsequent conversion of fibrinogen to fibrin, which is the structural matrix of blood clots. This targeted blockade stops the coagulation cascade at a crucial amplification stage.

Unlike standard heparin, Dalteparin Sodium has a longer half-life, more predictable bioavailability, and does not require routine blood clotting time monitoring (such as APTT). It is exceptionally well-tolerated and can be self-administered subcutaneously for outpatients.

Dalteparin Sodium (CAS 9041-08-1) is a widely prescribed low molecular weight heparin (LMWH) that plays a key role in cardiovascular and surgical care. Celesta provides high-quality services for Dalteparin Sodium third party manufacturing in India, delivering pre-filled syringes and sterile injectables to domestic and export markets.

Therapeutic Uses

Dalteparin Sodium is prescribed for:

• Deep Vein Thrombosis (DVT) Prophylaxis: Indicated to prevent blood clots in patients undergoing major surgeries.
• Venous Thromboembolism Treatment: Used for acute treatment of DVT and pulmonary embolism (PE) to prevent clot expansion.
• Acute Coronary Syndrome: Administered to manage unstable angina and non-Q-wave myocardial infarction alongside aspirin.
• Hemodialysis Clotting Prevention: Prevents clotting in extracorporeal systems during dialysis for renal failure.

Choosing a Dalteparin Sodium Manufacturer in India

The global demand for low molecular weight heparins continues to grow due to aging populations and rising surgical volumes. For pharmaceutical brand owners, partnering with a high-quality Dalteparin Sodium manufacturer is essential to secure stable supply lines. Preparing pre-filled syringes (PFS) and sterile vials requires advanced aseptic filling lines and nitrogen flushing capabilities. Sourcing from a WHO-GMP certified manufacturer in India ensures compliance with strict pharmacopoeias such as IP, BP, USP, and EP. Our partner WHO-GMP certified facilities provide reliable contract manufacturing services that meet global regulatory audit standards.

To request a quote, please contact our team. You can view our cardiovascular portfolio on our manufacturing listing page or read about our capabilities on our contract manufacturing page.

This makes Dalteparin Sodium one of the most sought-after molecules for third party manufacturing in India, with consistent demand from cardiology distributors and export-oriented companies.